Human growth hormone (hGH) antagonists are used to treat acromegaly, a disorder caused by excess human growth hormone. OPKO Biologics is developing a long acting hGH antagonist utilizing a stabilizer-based technology to extend its serum half-life and to reduce the frequency of injections, with the goal of reaching once weekly administration.